Sun Pharma share price slips 0.43% to ₹1,770 on November 2
Last Updated: 2nd November 2026 - 06:34 pm
Key Takeaways
- Sun Pharma closed at ₹1,770, down 0.43%, after a comparatively wide ₹54 intraday range between ₹1,722 and ₹1,776.
- The share recovered ₹48 from the session low but remained below its 50-day, 100-day and 200-day moving averages.
- The one-year return was positive at 4.69%, contrasting with negative one-, three- and six-month readings.
Sun Pharmaceutical Industries share price closed November 2 at ₹1,770, down 0.43% from the previous close of approximately ₹1,778. The stock opened at ₹1,770, rose to ₹1,776 and dropped sharply to ₹1,722 before recovering. It returned to its opening level by the close, ending ₹48 above the low and just ₹6 below the high. Volume was 3,555,936 shares.
The day's ₹54 trading range was sizeable compared with the final ₹7.70 decline. The recovery from ₹1,722 to ₹1,770 was the main intraday feature, even though the stock still ended lower than the previous session.
Sun Pharma remained below its reported moving averages. The 50-day DMA stood at ₹1,816.10, leaving a ₹46.10 difference. The 100-day DMA was ₹1,833.70, or ₹63.70 above the close. The 200-day DMA at ₹1,814.90 was ₹44.90 higher. The 50-day and 200-day averages were themselves separated by only ₹1.20.
Its 52-week range extended from ₹1,584 to ₹2,047. At ₹1,770, the share was ₹186 above the annual low and ₹277 below the high.
Return figures were negative across the shorter periods. One-month return was -1.72%, three months -11.08% and six months -2.12%. The one-year return, however, remained positive at 4.69%.
November 2 therefore ended with a small decline but a substantial recovery from the intraday low. Sun Pharma returned to its opening price by the close, while remaining below all three major moving averages.
Frequently Asked Questions
What was the Sun Pharma share price on November 2?
How much did Sun Pharma recover from its intraday low?
How did Sun Pharma compare with its moving averages?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.
5paisa Capital Ltd